Possible association between peliosis hepatis and diethylstilbestrol: Report of two cases.
In the two cases presented here, peliosis hepatis occurred after prolonged administration of diethylstilbestrol for treatment of prostatic carcinoma. Hepatic dysfunction has not been reported in previous trials of this drug, and further study is needed to confirm an association between diethylstilbestrol and peliosis.
D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D056486:Chemical and Drug Induced Liver Injury; D004054:Diethylstilbestrol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000188:drug therapy; D011693:Purpura / Q000139:chemically induced*
D004054:Diethylstilbestrol